Navigation Links
Auro Green

ProductsAuro Green
Company Aurolab
Item Auro Green
Features 
Description Aurogreen active ingredient indocyanine green-ICG) is a diagnostic dye used mainly for ophthalmic angiography, cardio-circulatory blood volume diagnosis, and liver function diagnosis. Aurogreen is a safe dye with only a minor side - effect like iodide allergy reported with its clinical use. It is safer than fluorescein sodium. Vomiting and nausea are extremely uncommon during ICG angiography. No complications were reported in a study using intravenous ICG doses of 150 to 200 mg.
Info Aurolab
Customer Service: + 91-452-2535573
Web site: http://www.aurolab.com

Related medicine products :

1. Green Strabismus Hook
2. Green Straight Fixation Forceps
3. Green Fixation Forceps
4. Scoville-Greenwood Bayonet Forceps
5. Greenberg Handrest
6. Greenberg Primary Bar
7. Greenberg Secondary Bar
8. Greenberg Long Retractor Arm
9. Greenberg Short Retractor Arm
10. Greenberg Tapered Retractor Blades
11. Greenberg Universal Retractor Case
TAG: Auro Green
... Substitutes a natural alternative to autografts. ... but such grafts may introduce the risk of immune ... has developed the Pro Osteon family of bone graft...s a broad range of bone grafting alternatives that...
Schuknecht-Weitlaner retractor, sharp, angled arms.
Sharp Weitlaner Retractor.
Baby Weitlaner retractor, blunt, 4".
Medicine Products:
(Date:5/16/2008)... that Primary care medicine is in a precipitous de...merican College of Physicians (ACP), today joined...sumers to issue a call for comprehensive reforms t...nd other primary care physicians. , During a pa...ne in the U.S., Dr. Dale and other panelists spoke...
(Date:5/16/2008)...ervices for Frail Seniors and People With,Disabili...ire/ -- Thousands of,homecare workers across the s...proposed cuts to hours of service, wages and benef...ulnerable workers and the,people they serve deeper...rvices for seniors and people with disabilities fr...
(Date:5/16/2008)...alth Institute with 10,000 Sensual O Condom Packs ...Mansion Fundraiser, LOS ANGELES, May 16 /PRNewswi... B artist J Kwon known best for his hit song "Ever...ng the Urban Health Institute (UHI) with,10,000 Se... The donation is,being made to promote the launch ...
(Date:5/16/2008)... who would benefit most from chemo after surgery, ... News) -- A panel of 15 genes may help determine w... cancer will experience a recurrence and, therefor... shows. , By extension, the same genetic signa...ve forms of the cancer who would be able to forego...
Breaking Medicine News(10 mins):Health News:ACP says major system reforms needed to improve the state of primary care medicine in the US 2Health News:Homecare Workers Outraged by Proposed Cuts, Wage Reductions 2Health News:Everybody in the Club Scream O! 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3
...t deadly form of skin cancer , advanced melanoma c...ts with tumor proteins, say researchers according ...ect vaccinating patients with tumor antigens (call...e cells, which are known as killer T-cells. It was...
...iscovery could help prevent complications for preg...lampsia. Preeclampsia typically develops after the...gh blood pressure, // edema, and protein in the u...here a sharp rise in blood pressure causes the mot...
... killer cells are part of the body’s immune system...ome cancers, particularly leukemia. A new study sh...emia // patients may lie in artificially stimulat...member. Researchers say this method could help tr...
...hers say they have found that stem cell therapy is...uring the study injecting stem cells from one pig'...ig's damaged heart muscle restored the heart's fun...hers studied 14 pigs, whose circulatory systems ar...
Other Medicine News:
(Date:5/16/2008)... MicroRNAs as Potential Biomarkers -- for Lung Can...in Patients With Cancer of Unknown Primary ...ively Identify Cancer Types With High Sensitivity ...is and Treatment of Cancer Results of microRNA Si... Accuracy Exceeding 90% and Specificity of ...
(Date:5/16/2008)...ANX-530 Demonstrates Statistically Significant Red...y Observations, - Abstract to be published in 2008... Clinical Oncology, SAN DIEGO, May...cals,Inc. (Amex: ANX ) announced today that, in ...X-530 demonstrated a statistically significant red...
(Date:5/15/2008)...BASEL, Switzerland, May 15 /- Patient...ld,s most common cancers, can expect,further treat...rceptin(R),(trastuzumab) following new data that i...Clinical Oncology (ASCO) annual meeting in Chicago...will attend the meeting which,is the premier event...
(Date:5/15/2008)...afety and Efficacy Clinical Data from Prostate, Co... Cancers -, - Company to Hold Investor Event on S...ANCISCO, Calif., May 15 /- ...biopharmaceutical company focused,on oncology, tod...om three,clinical trials of picoplatin, in various...
Breaking Medicine Technology:Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 2Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 3Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 4Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 5Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 6ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 2ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 3ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 4ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 5New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 2New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 3New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 4New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 5New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 6Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 2Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 3Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 4Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 5Court Orders Service Union and Its President Andy Stern 3A Stop Stalking and Harassing Registered Nurse Leaders and Staff of California Nurses Assn NN 17029 1Court Orders Service Union and Its President Andy Stern 3A Stop Stalking and Harassing Registered Nurse Leaders and Staff of California Nurses Assn NN 17029 2Court Orders Service Union and Its President Andy Stern 3A Stop Stalking and Harassing Registered Nurse Leaders and Staff of California Nurses Assn NN 17029 3Human Genome Sciences Advances Oncology Portfolio 4655 1Human Genome Sciences Advances Oncology Portfolio 4655 2Human Genome Sciences Advances Oncology Portfolio 4655 3Human Genome Sciences Advances Oncology Portfolio 4655 4Human Genome Sciences Advances Oncology Portfolio 4655 5Human Genome Sciences Advances Oncology Portfolio 4655 6Timing of HRT May Influence Heart Risks 17022 1Timing of HRT May Influence Heart Risks 17022 2Anthem Blue Cross Employee Assistance Program to Help Reduce Employee Absenteeism 17017 1Anthem Blue Cross Employee Assistance Program to Help Reduce Employee Absenteeism 17017 2
... and Dose Proportionality of,Company,s Once-Daily ...al -, LAVAL, QC, June 29, 2007 /PRNewswire-FirstCa...present a poster discussing the dose,titration of ...International Forum on Pain Medicine to be held Ju...oster compares two different titration schedules f...
...Program for Oral Compounds,to Treat Alcohol Depen..., 2007--Alkermes, Inc.,(Nasdaq: ALKS) today announ...rial of ALKS 29 in alcohol dependent patients. Bas...ward with its,development program for oral product...s a combination of two agents with distinct,pharma...
Other Medicine Technology:Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 2Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine 3Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 2Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 3Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 4